Navigation Links
Ceregene Announces Two Key Additions to Leadership Team
Date:4/23/2008

any, Schering-Plough Corporation, Hoechst-Roussel Pharmaceuticals and Ayerst Laboratories. Maurice received a BA degree in environmental biology from Rutgers University, an MS degree in microbiology from Louisiana State University and an MBA in finance from Fairleigh Dickinson University. He is also a Chartered Financial Analyst (CFA).

Andrea Loewen-Rodriguez, a regulatory affairs professional with more than 18 years of biopharmaceutical industry experience, joins us from the regulatory affairs division at Biogen Idec, where she has been since 2000. Her responsibilities included developing and implementing global regulatory strategies and submissions for multiple products in clinical development. Prior to Biogen Idec, Ms. Loewen-Rodriguez held various positions with Nexell Therapeutics and Baxter Healthcare Corp. Andrea holds a Regulatory Affairs Certification and received her BA degree in biology from Gustavus Adolphus College.

About Ceregene

Ceregene, Inc. is a San Diego-based biotechnology company focused on the delivery of nervous system growth factors for the treatment of neurodegenerative disorders using gene delivery. Ceregene's clinical programs include CERE-110, an AAV2 based vector expressing nerve growth factor that is currently in Phase 1 studies for the treatment of Alzheimer's disease, and CERE-120 (AAV2-Neurturin) which has completed enrollment of a controlled Phase 2 study for Parkinson's disease. CERE-135 and CERE-140 are in preclinical development for ALS (Lou Gehrig's disease) and ocular disorders, respectively. Ceregene was launched in January 2001. The company's investors include Alta Partners, MPM Capital, Investor Growth Capital and Cell Genesys, Inc. (Nasdaq: CEGE) as well as Hamilton BioVentures and
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ceregene Appoints Joao Siffert, M.D. to the Position of Chief Medical Officer
2. Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call
3. Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
4. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
5. Rochester Medical Announces Second Quarter 2008 Earnings Conference Call April 29, 2008
6. BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock
7. UltraTape Announces Sample Kits Available for Purchase Through Website
8. IMPAC Medical Systems Announces 2008 Laboratory Professionals of the Year
9. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
10. Fufeng Announces 2007 Annual Results
11. Pharmacyclics Announces It Received Nasdaq Notification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Cirrascale ... blade-based and rackmount computing and storage infrastructure for ... launch of its high density scale-out, two-in-one video ... Slipstream™ RM1622D . The high density, two-in-one system ... product family with Intel® Iris™ Pro graphics P6300 ...
(Date:6/2/2015)... NEWTOWN, Pa. , June 2, 2015   ... services and technology provider, today announced that David ... has been named Executive Vice President and Chief Financial ... 8, 2015. Peters brings more than 25 ... in pharmaceutical services. "David has extensive and deep knowledge ...
(Date:6/2/2015)... KONG , June 2, 2015 /PRNewswire/ -- China Cord Blood ... and "our"), China,s leading provider of ... stem cell storage services, today announced that the Special Committee ... appointed Houlihan Lokey ( China ) ... & Hamilton LLP as its United States ...
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3BioClinica Names David Peters New Chief Financial Officer 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3
... Schering-Plough Corporation (NYSE: SGP ) today ... in Japan, has received marketing approval for REMERON(R) ... major depressive disorder.(1) The product was developed jointly ... Meiji Seika will market the product under the ...
... US Oncology, Inc . today announced that ... pharmacy service, has exceeded the $15 million mark and has assisted ... since the launch of Care Advantage in August 2006. , ... as a positive resource to help so many cancer patients obtain ...
... SHANGHAI, July 9 /PRNewswire-Asia/ -- ... of ShangPharma Corporation, today,announces that it has expanded ... first biopharmaceutical company dedicated to the,development of novel ... will provide integrated services in the areas of ...
Cached Biology Technology:REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 2REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 3REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 4REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 5OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 2OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 3OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 4Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration 2
(Date:5/25/2015)... 25, 2015  Australia,s market for wearable technologies is ... saw the advent of several trials and prototypes. The ... is expected to ignite interest in wearables as well ... Australia . This in turn will spur greater ... new partnerships amongst vendors and distributors. ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... a species classified as vulnerable and at risk of extinction, ... or more. However, the youngest tortoises are more vulnerable, and ... study by Spanish researchers, who analysed the impact of a ... in Murcia (Spain) on these reptiles. "Tortoises can ...
... common form of malignancy in adult Caucasian populations, with more ... alone. Lifestyle risk factors but , ... to the aging structure of Western populations, and as a ... high sun exposure, which is a key risk factor for ...
... fisheries could pose a more serious threat to marine ... of Exeter, published today (19 July) in the British ... that tens of thousands of turtles from across the ... fisheries. Focusing on fisheries in Peru, the study ...
Cached Biology News:Tortoise populations can withstand fires every 30 years 2Some cutaneous HPV types may be involved in non-melanoma skin cancer development 2Study shows small-scale fisheries' impact on marine life 2
Acetyl CoA Carboxylase Antibody...
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: